ENvue Medical (FEED) Research & Development (2014 - 2026)

ENvue Medical (FEED) has reported Research & Development for 13 consecutive years, with $1.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Research & Development rose 17.91% year-over-year to $1.2 million in Q2 2026; TTM through Jun 2026 was $3.4 million, a 58.22% increase from a year earlier, with the FY2025 full-year figure at $2.5 million, up 174.26% from the prior year.
• Research & Development was $1.2 million for Q2 2026 at ENvue Medical, up from $772000.0 in the prior quarter.
• Over five years, Research & Development peaked at $1.2 million in Q2 2026 and troughed at $165000.0 in Q1 2024.
• A 5-year average of $429833.3 and a median of $241000.0 in 2023 frame the typical range for Research & Development.
• Across the five-year window, Research & Development slumped 32.48% in 2022 and surged 410.55% in 2025, its largest moves.
• Over 5 years, Research & Development stood at $205000.0 in 2022, then increased by 13.66% to $233000.0 in 2023, then surged by 51.07% to $352000.0 in 2024, then jumped by 74.72% to $615000.0 in 2025, then jumped by 94.8% to $1.2 million in 2026.
• The last three Research & Development figures came in at $1.2 million (Q2 2026), $772000.0 (Q1 2026), and $615000.0 (Q4 2025), per Business Quant data.